Healthcare - Biotechnology - NASDAQ - US
$ 3.43
-9.26 %
$ 152 M
Market Cap
-2.01
P/E
INCOME STATEMENT
103 K
REVENUE
-52.1 M
OPERATING INCOME
-51.8 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Checkpoint Therapeutics, Inc.
| Revenue | 103 K |
| Cost Of Revenue | 43.6 M |
| Gross Profit | -43.5 M |
| Operating Expenses | 52.3 M |
| Operating Income | -52.1 M |
| Other Expenses | -301 K |
| Net Income | -51.8 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Revenue | 0.1 | 0.2 | 0.3 | 1.1 | 1.7 | 3.5 | 1.7 | 2.6 | 0.6 |
| GROSS PROFIT | |||||||||
| Cost Of Revenue | 43.6 | 49.8 | 48.5 | 16.4 | 19.3 | 33.7 | 19.1 | 20.3 | 11.3 |
| Gross Profit | (43.5) | (49.6) | (48.2) | (15.3) | (17.6) | (30.1) | (17.4) | (17.7) | (10.7) |
| OPERATING INCOME | |||||||||
| Operating Expenses | 52.3 | 58.5 | 57.0 | 24.3 | 26.6 | 40.2 | 24.5 | 24.7 | 13.8 |
| Selling, General and Administrative Expenses | 8.7 | 8.7 | 8.5 | 7.9 | 7.2 | 6.6 | 5.4 | 4.5 | 2.5 |
| Research and Development Expenses | 43.6 | 49.8 | 48.5 | 16.4 | 19.3 | 33.7 | 19.1 | 20.3 | 11.3 |
| Operating Income | (52.1) | (58.3) | (56.7) | (23.2) | (24.9) | (36.7) | (22.8) | (22.2) | (13.2) |
| PRE-TAX INCOME | |||||||||
| Interest Income Expense | 0 | 4.3 | 0 | 0 | 0 | 0 | 0 | 0.3 | 0.2 |
| Total Other Income | 0.3 | (4.3) | 53 K | 0.1 | 0.1 | 0.4 | 98 K | (0.3) | (0.7) |
| Pre-Tax Income | (51.8) | (62.6) | (56.7) | (23.1) | (24.7) | (36.4) | (22.7) | (22.5) | (13.9) |
| NET INCOME | |||||||||
| Tax Provision | 0 | 4.3 | 53 K | (0.1) | (0.1) | (0.5) | (22.7) | (22.1) | 0.2 |
| Net Income | (51.8) | (66.9) | (56.6) | (23.0) | (24.6) | (36.4) | (22.7) | (22.5) | (13.9) |
| EPS | 2.77 | 7.57 | 7.45 | 4.11 | 6.96 | 12.7 | 10 | 10.4 | 5.69 |